ABBV—I don’t think it’s company-specific. Big Pharma have had a bit of a run-up lately, possibly a result of the FTC’s being rebuffed in its attempts to block mergers.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”